A high-throughput microfluidic mechanoporation platform to enable intracellular delivery of cyclic peptides in cell-based assays.
Journal Information
Full Title: Bioeng Transl Med
Abbreviation: Bioeng Transl Med
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Engineering, Biomedical
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"data s1."
"CONFLICT OF INTEREST STATEMENT All authors that are present or former employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ or MSD International, Singapore may hold stocks and/or stock options in Merck & Co., Inc., Rahway, NJ. Srinivasaraghavan Kannan and Chandra S. Verma are co‐founders of Sinopsee Therapeutics and Aplomex; the current work does not have a conflict."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025